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Abstract
Background: As in other countries, the traditional doctor-patient relationship in the Japanese healthcare system
has often been characterised as being of a paternalistic nature. However, in recent years there has been a gradual
shift towards a more participatory-patient model in Japan. With advances in technology, the possibility to use
digital technologies to improve patient interactions is growing and is in line with changing attitudes in the medical
profession and society within Japan and elsewhere. The implementation of an online patient engagement platform
is being considered by the Myotonic Dystrophy Registry of Japan. The aim of this exploratory study was to understand
patients’ views and attitudes to using digital tools in patient registries and engagement with medical research in Japan,
prior to implementation of the digital platform.
Methods: We conducted an exploratory, cross-sectional, self-completed questionnaire with a sample of myotonic
dystrophy (MD) patients attending an Open Day at Osaka University, Japan. Patients were eligible for inclusion if they
were 18 years or older, and were diagnosed with MD.
Results: A total of 68 patients and family members attended the Open Day and were invited to participate in the
survey. Of those, 59 % submitted a completed questionnaire (n = 40). The survey showed that the majority of patients
felt that they were not receiving the information they wanted from their clinicians, which included recent medical
research findings and opportunities to participate in clinical trials, and 88 % of patients indicated they would be willing
to engage with digital technologies to receive relevant medical information. Patients also expressed an interest in
having control over when and how they received this information, as well as being informed of how their data is
used and shared with other researchers.
Conclusion: Overall, the findings from this study suggest that there is scope to develop a digital platform to
engage with patients so that they can receive information about medical care and research opportunities. While
this study group is a small, self-selecting population, who suffer from a particular condition, the results suggest
that there are interested populations within Japan that would appreciate enhanced communication and interaction
with healthcare teams.
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Background
Digital technologies are increasingly being applied in all
areas of the patient pathway, both within research and
the clinic, throughout healthcare systems across the world.
Increasingly, the use of these technologies is focused on
direct engagement with patients. The engagement oppor-
tunities of tools such as dynamic consent [1], a personalised
electronic communication interface which enables people
to give and change consent for involvement in research, are
being realised in response to research participants' increas-
ing support for greater interaction with research [2, 3].
In 2001, Japan launched the ‘e-Japan Priority Policy
Program’ strategy, aimed at creating a society where
everyone could benefit from IT in various different ways,
including through the digitisation of health and medical
care [4]. This has been implemented in a number of
ways, including electronic medical records (EMR) [5]
and the storage of patient data for research [6]. While
this is promising, there has been little exploration of the
value of such technologies in patient-facing processes.
The traditional doctor-patient relationship in the
Japanese healthcare system has been of a paternalistic
nature [7], which means it is not clear whether pa-
tients would welcome these initiatives or not. Higuchi
conducted a comparison between Japanese and American
doctor-patient interactions in the early 1990s and reported
that deferring to doctors was consistent with people’s
views of autonomy in Japan. In this study many Japanese
patients did not accept the self-determined American style
of consultation, but preferred to choose to stay unin-
formed and rely on the judgement of doctors [8]. How-
ever, in recent years there has been a gradual shift towards
a more participatory patient-doctor model that allows a
greater consideration of patient views in decision-making.
Slingsby reported increasing active participation in the
medical decision-making process, but also within the
medical treatment process [9].
Despite this transition, there is still wide spread satisfac-
tion with the traditional Japanese patient-doctor model
[10], and a significant behaviour change may be required
before digital solutions to support medical and research
processes will extend to enable direct interaction with
Japanese patients. What is not clear, is whether the
bottleneck to enhance patient interaction is due to a
lack of interest from participants, lack of provision, for
cultural reasons or others. Given these unresolved ques-
tions, in instances where researchers are considering op-
portunities to set up electronic patient registries, it is not
yet clear whether the adoption of technology to enable en-
hanced interaction between participants and the registry
would be welcomed by participants, to allow greater con-
trol over their involvement in medical care and research.
To explore this question, in contribution to the develop-
ment of a registry for patients with myotonic dystrophy
(MD), we have surveyed patients directly, to ascertain
their views and attitudes to using an electronic patient




We conducted an exploratory, cross-sectional, self-
completed questionnaire with a convenience sample of
MD patients attending an Open Day at Osaka University,
Japan. The Open Day was held in January 2015 and was
organised by the Clinical Research Consortium for MD.
Sample population
Patients were eligible for inclusion if they were 18 years
or older, older, diagnosed with MD and attending an Open
Day for patients at Osaka University Nakanoshima Center,
Japan.
Recruitment
The patient Open Day was advertised in two ways. Firstly,
all MD patients who were attending outpatient clinics in
Osaka University and Toneyama National Hospital, and
met the eligibility criteria, were invited to attend by their
clinician. Secondly, adverts were posted on hospital web-
sites; they included details of the date, venue and outline
for the patient Open Day. All patients attending the Open
Day were invited to participate in the survey; each patient
was given a questionnaire upon arrival to the Open Day
and was invited to complete it at some point during the
day. Researchers collected completed questionnaires as
patients left the Open Day.
Questionnaire design
The questionnaire was designed in a number of stages.
Firstly, the initial themes were developed through dis-
cussions with all members of the research team, which
included specialist clinicians and research scientists. Three
themes were identified: current satisfaction with informa-
tion from clinicians and researchers; current use of elec-
tronic devices; and acceptability of using electronic devices
to engage with healthcare professionals and researchers.
Secondly, MPT and KK developed a draft of specific
sections of the survey, which was then modified by GY
and JM. All members of the research team discussed
the structure, content and language, and the questionnaire
was redrafted a number of times, with careful consideration
of the language use and meaning. The final draft consisted
of a mixture of 16 closed and open-ended questions to gain
a breadth and depth of patient views and attitudes, and
took approximately 5 to 10 min to complete. A full copy of
the questionnaire can be found as an additional file [see
Additional file 1: Patient Survey in English.pdf]. To minim-
ise social-desirability bias, the questionnaire collected
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no identifiable data from patients, ensuring anonymity.
Consent was implied by the submission of a completed
questionnaire.
Analysis
Data was entered into a spreadsheet and participant re-
sponses were summarised as frequencies and percentages.
Some participants did not answer all questions, therefore,
the sample size varied by question. Percentages are calcu-
lated using total sample size (n = 40). Descriptive summary
plots were generated to provide a visual representation of
participants' responses to specific survey questions. Two-
by-two tables were used to calculate proportions within
specific strata of participants and Chi-squared test for inde-
pendence was used to explore relationships between cat-
egorical questionnaire variables. Some questions permitted
multiple responses. Therefore, some table responses do not
add up to 40; these include questions on the type of infor-
mation participants would like, what participants would like
to tell doctors or researchers about, and what features of
digital technologies would be important to participants.
Analyses were performed using STATA 14.0 [11].
Results
A convenience sample of 40 patients was recruited to
the study. A total of 68 patients and family members
attended the Open Day and were invited to participate
in the survey. Of those, 59 % submitted a completed
questionnaire (n = 40); one questionnaire was completed
by a family member on behalf of the patient. All partici-
pants were Type 1 MD patients and the distribution of
participant ages and gender are presented in Table 1.
The majority of participants were females (62 %) and be-
tween the ages of 30 and 49 years old (56 %). Participants'
age and gender were not associated with questionnaire
responses.
Current communication with clinicians and researchers
Participants were initially asked to choose the areas in
which they would like to receive more information from
clinicians and researchers in the field. The most fre-
quently reported areas of interest were associated with
patients' disease state and prognosis, and information re-
lated to medical research. Of those who expressed an
interest in learning more about medical research relating
to MD, approximately 65 % of participants felt they ei-
ther never received or received only a small amount of
this information from clinicians or researchers. Results
indicated there was no evidence of relationships between
the types of information wanted, the amount of that in-
formation they currently receive or how satisfied partic-
ipants are with day-to-day communication with their
doctor (Table 2).
Table 3 presents the type of information patients wish
to tell their doctor about and how much of that informa-
tion participants feel they are currently able to discuss.
Results indicated that a higher proportion of participants
felt they were able to discuss their physical conditions
compared to issues about their mental health and lifestyle.
Results also suggested that wanting to discuss issues relat-
ing to mental health or lifestyle was associated with a
higher level of dissatisfaction with day-to-day commu-
nication with their doctor. Interestingly, satisfaction with
day-to-day communication was associated with being able
to tell doctors and researchers their issues, but was not as-
sociated with whether they received the information they
were interested in (Table 4).
The use of digital technologies
Participants were then asked about their current use of
digital technologies and whether they would be happy to
register and engage with an online patient registry. Over-
all, participants expressed support for using computers,
laptops or tablets to engage with medical care and research.
The majority of participants (73 %) reported using
computers, tablets or smartphones on a daily basis, with
reasons for use ranging from work (38 %), communicat-
ing with friends and family (48 %), and entertainment
purposes (48 %).
Table 5 presents participants' current and future use of
digital technologies. Approximately 70 % of participants
reported using a computer or mobile terminal to answer
questions or search for information about health or dis-
ease and 88 % reported they would be happy to use a
computer or tablet to communicate with doctors or re-
search health information in the future.
Results indicated that participants who had used
digital technologies to find out information about health
or disease in the past were significantly more likely to
use a computer or tablet to communicate with doctors
or researchers in the future (X2 (4, N = 38) = 11.71, p =
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0.020). Interestingly, of those who had never used digital
technologies to find out about health or disease, ap-
proximately two thirds were interested in using com-
puters or tablets in the future to communicate with
their doctor or research the topics about MD they re-
ported to be interested in; only four patients (10 %) re-
ported no interest in using computers or tablets in
relation to their disease in the future (Fig. 1).
When patients were asked about the three most import-
ant features of an electronic device that enabled patients
to engage with doctors and research, the three most
frequently reported features were: that their data is private
and confidential (45 %); that it provides useful advice
about treating both physical and mental symptoms of MD
(40 %); and that the content is easy to understand (35 %).
Interestingly, only 8 % of patients reported that the ability
to access an application on their smartphone or tablet
would be important to them (Table 5). Participants' choice
of features were not associated with previous use of digital
technologies or preferences for future use.
Preferences for engaging with digital technology
Participants were also asked a number of questions re-
garding their views on receiving invitations to take part
in medical research studies via an electronic patient
registry. The majority of participants (68 %) stated they
would like to receive emails about opportunities to
participate in research; however, when asked about
changing this preference, 75 % of all participants felt
patients should be able to do this at any given time.
The survey also explained that data from the patient
registry might be shared with other researchers, includ-
ing pharmaceutical companies. When asked about their
preferences regarding data-sharing, the vast majority
(78 %) of participants wanted to be informed in some
way – either every time or at regular intervals – about
how their data was being shared (Table 6).
Discussion
The main aims of this survey were to gauge patients’
interest in receiving information about medical research
and to explore their views on using an electronic patient
registry to communicate with healthcare professionals
and researchers. The overall findings indicate that the
MD patients (and in one case, family members) who
participated in this survey were very interested in learn-
ing about medical research related to MD and would
support the use of an electronic patient registry that they
could use to engage with clinicians, find out more about
their condition, and also discover opportunities to par-
ticipate in medical research.
The findings from this survey suggest that currently
the communication needs of patients, relating to research
opportunities and general healthcare information, are not
Table 2 The types of information participants would like to receive from doctors and researchers, the amount of information they
currently receive and overall satisfaction with communication (n = 40)
Receive information Communication with doctor
All or some Little or none p-value Satisfied Dissatisfied p-value
n (%) n (%) n (%) n (%)
Types of information
Disease (general) 8 (62) 5 (38) 0.390 12 (92) 1 (8) 0.058
Symptoms 8 (42) 11 (58) 14 (74) 5 (26)
Treatments 9 (41) 13 (59) 16 (76) 5 (24)
Prognosis 7 (28) 18 (72) 17 (74) 6 (26)
Other patients 6 (46) 7 (54) 11 (85) 2 (15)
Medical research (findings) 11 (35) 20 (65) 19 (68) 9 (32)
Medical research (participating) 10 (43) 13 (57) 13 (62) 8 (38)
Table 3 The topics that participants would like to discuss with doctors and researchers, the amount participants currently discuss
and overall satisfaction with communication (n = 40)
Discuss information Communication with doctor
All or some Little or none p-value Satisfied Dissatisfied p-value
n (%) n (%) n (%) n (%)
Important topics
Physical symptoms 15 (60) 10 (40) 0.007 15 (60) 10 (40) 0.039
Mental health 5 (36) 9 (64) 7 (47) 8 (53)
Lifestyle/Household 4 (24) 13 (76) 8 (44) 10 (56)
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always being met. This is not necessarily unique to MD
patients in Japan, as similar findings have been reported
with other patient groups in other countries; for example
in the UK a national survey conducted by the National
Health Service (NHS) found that approximately 53 % of
the cancer patients surveyed were given no information
about relevant research and would have liked to be more
informed about opportunities to participate [12].
The results also indicated that a higher proportion of
participants felt they were not able to tell doctors or re-
searchers about issues related to their mental health or
lifestyle and household, compared to discussing physical
symptoms. Being able to tell doctors or researchers
about important issues was also associated with being
satisfied with day-to-day communication with their doctor.
Interestingly, receiving information was not associated with
satisfaction. These results suggest that while this group of
patients want information about their condition, they also
value the opportunity to be listened to, and thus for a two-
way communication channel. Similar findings were re-
ported in a survey conducted in the UK with rare disease
patients; only a third of respondents reported feeling like
they received sufficient social and psychological support
and approximately one quarter felt they receive adequate
support with financial concerns related to their condition
[13]. A lack of psychological support is of particular con-
cern as there is evidence to suggest an association between
suffering with MD and an increased risk of psychological
conditions, such as depression and anxiety disorders, which
can severely impact quality of life [14].
This suggests that a platform to enable greater levels
of communication could be a positive improvement to
the existing system, particularly given that several of the
survey participants reported to have already used an
electronic device to search for health information them-
selves. One possibility would be to use a digital communi-
cation system based on the concept of dynamic consent in
which patients are connected with research projects and
can access a record of their consent choices relating to the
use of their samples and data, which they can change over
time, if they wish to. Through such a platform they could
also receive information about the research project and
how it is progressing [1]. Furthermore, the digital system
Table 4 The amount of desired information participants receive,




n (%) n (%)
Receiving information from doctor/researcher
All or some 13 (54) 11 (46) 0.173
Little or none 10 (77) 3 (23)
Discuss information with doctor/researcher
All or some 15 (88) 2 (12) 0.002
Little or none 6 (37) 10 (63)
Table 5 Proportions of participants' use of digital technologies in healthcare (n = 40)
Number Percent
Have you ever used a computer or mobile terminal for collecting information about or answering questions about health or disease?
Yes, many times 20 50
Once or twice 8 20
Never 11 28
Would you be happy to use a computer or tablet to communicate with a doctor or search for the types of information you are interested in?
Yes 21 53
Yes, but it would depend on certain conditions 14 35
I would prefer not to 3 8
Definitely not 1 3
What do you think are the three most important features of a computer or tablet device that enables patients to engage with doctors or research?
Easy to view and enter information 11 28
Making the content easy to understand 14 35
Ability to use smartphone or tablet 3 8
Family members able to enter information on your behalf 6 15
Providing prompt responses to questions 7 18
Your information and privacy is well protected 18 45
Providing advice on how to treat both physical and mental symptoms 16 40
Making it useful for progress in medical research, diagnosing and treating patients 13 33
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could pave the new way to facilitate communication of re-
search participation within a family and develop the trust
between the family and professionals [3].
The positive response to questions relating to the use
of tablets, smartphones and computers to access health-
related information, and the demonstration that a large
proportion of this patient group are already confident in
using technology for this purpose indicates that it is
worth exploring this opportunity further. It is also inter-
esting to note that while participants are interested in
engaging through digital means, they would want to
maintain control over this interaction; the majority of
patients indicated they would like to be informed when
their data are being shared for research purposes and
also to have control over when and how they receive in-
formation about opportunities for research participation
via email or website updates. This is particularly
surprising given how much of a shift it is from the histor-
ical viewpoint of uninformed autonomy. Based on these
results, it may be appropriate to consider implementing a
platform that would enable continued engagement and
communication with participants.
Despite the positive responses to using technology in
healthcare, patients indicated that privacy was an im-
portant factor when using healthcare applications. Inter-
estingly, a study conducted in the US reported that only
a minority of patients had concerns over privacy issues
in relation to healthcare technology and linked web mes-
saging with clinicians [15]. A systematic literature review
that summarised 12 studies conducted in North America
and Europe, also reported that privacy did not appear to
be a significant concern for patients [16]. However, pa-
tients included in the systematic review studies were from
the general population, rather than rare disease patients.
This, along with cultural differences, may account for the
difference in attitudes towards privacy. Traditionally, there
are negative implications associated with genetic disorders;
inherited conditions were considered to bring shame upon
a family [17, 18]. While this attitude has been changing
over the past few decades, with more widespread access
and acceptance of genetic counsellors, there still remains
discrimination and prejudice regarding genetic disorders,
such as MD [19, 20]. There are also a number of examples
of projects incorporating health data that have been
thwarted as a result of privacy concerns relating to data
usage. One example is the care.data NHS initiative in the
UK, which aimed to extract patients' medical data and
share it with a central database using an opt-out system.
The poor communication of this initiative has resulted in
widespread public and professional concern over the priv-
acy and control that patients have over their medical data
[21]. Nonetheless, there is evidence to suggest that even
those with higher than average privacy concerns are sup-
portive of electronic platforms to share health data in the
right context [22].
The patient views reported in the survey findings are
consistent with the idea that there is a shift in Japanese
culture and patients want to take more of a participatory
role in their healthcare choices [9]. The interest demon-
strated by this group may be related to their status as
MD patients, and thus be in response to their general
interest in learning more about their condition and how
it influences their quality of life. Further research with
alternative patient groups and healthy populations will
be necessary to determine whether this standpoint is re-
flective of the general public, or specific to this inter-
ested group.
Strengths and limitations
This study has a number of strengths. Primarily, it is





Yes (many times) Once or twice No
Y P N Y P N Y P N
Fig. 1 Frequency of participants who have reported they would use
digital technologies to engage with healthcare in future (Y = Yes,
very keen/P = Yes, depending on conditions/N = No), by frequency
of participants' past use of computers, laptops and tablets to search
for healthcare information (Yes (many times) / Once or twice / No)
Table 6 Participant attitudes to receiving information regarding
opportunities to participate in medical research and participant
data-sharing (n = 40)
Number Percent
Would you like to be informed about opportunities to participate in
research via email or our website?
Yes 27 68
No 2 5
I don’t know 8 20
Would you like to be informed every time your registry data is shared
with other researchers or pharmaceutical companies?
I would like to be informed on every occasion 17 43
I would like to be informed at regular intervals 14 35
There is no need to inform me 5 13
I don’t know 2 5
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electronic patient registry to communicate with healthcare
professionals and researchers in Japan. Furthermore, the
questionnaire was anonymous and self-completed; there is
evidence to suggest that observational health research
studies are particularly vulnerable to social-desirability
bias in Japan, which has been attributed to the trad-
itionally conservative Japanese culture [23]. By main-
taining anonymity, we hope to have obtained more
honest responses. While many of the respondents were
women, a broad range of age groups were represented
by the survey, ensuring that respondents weren’t just
from a particularly technologically-savvy generation.
However, there are also a number of limitations that
must be discussed. Firstly, the study recruited a small,
self-selecting group of patients that had volunteered to
take part in the patient Open Day, and thus were already
demonstrating an interest in healthcare and research
communication. The findings of this survey therefore
may not be reflective of Japanese society in general, but
do suggest that there are interested populations within
Japan that would appreciate enhanced communication
and interaction with healthcare teams. Therefore, the
findings from this pilot study indicate that it would be
appropriate for more work to be conducted to explore
these issues in a wider population, including citizens and
other patient groups. Secondly, while it would have been
interesting to collect further socio-economic information
from the participants, for example relating to education
and income, there was a possibility that due to the small
sample size attending the Open Day, patients may have
been identifiable from their responses.
Conclusions
Overall, the findings from this survey have demonstrated
that many MD patients in Japan may be dissatisfied with
the current communication with clinicians and other
healthcare professionals and would welcome a digital
platform to engage with clinical and research teams and
learn more about medical research and opportunities to
participate. The significant interest shown in both re-
ceiving information, and in making decisions about in-
volvement, use of data and the types of information they
receive was of particular interest, given how different
this is from the widespread perceptions of Japanese
healthcare and the role of patients.
The initial results presented by this survey provide the
foundation for a number of new lines of enquiry. Firstly,
whether different patient groups report similar experi-
ences and have similar interests in receiving more infor-
mation. Secondly, whether electronic platforms already
being rolled out in other countries could be applied in
Japanese clinical and research settings. Finally, further
exploration of the sorts of conditions that would need to
be applied if data were to be used for research, and
contributed electronically, and how much control partici-
pants would want on setting these conditions.
Additional file
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